MediciNova reaches 200-patient enrollment in NIH-funded ALS study
Go back to MediciNova reaches 200-patient enrollment in NIH-funded ALS study| Medicinova, Inc. (NASDAQ: MNOV) | Delayed: 3.32 -0.13 (3.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.45 | 52 Week High | $10.16 | |||
| Open | $3.20 | 52 Week Low | $2.91 | |||
| Day High | $3.62 | P/E | N/A | |||
| Day Low | $2.72 | EPS | $-0.41 | |||
| Volume | 1,638,044 | |||||
